ZENITH HEALTH CARE LTD. (ZENITHHE)

BSE: ₹3.27
Stock Performance
Corporate Announcements
Announcement under Regulation 30 (LODR)-Newspaper Publication

Paper Cuttings of Published Audited Financial Result for the Quarter and year ended 31st March, 2026

2026-05-30 13:54:49
Appointment Of Internal Auditor

Appointment of Internal Auditor

2026-05-29 17:12:23
Announcement under Regulation 30 (LODR)-Change in Management

Appointment of Internal Auditor for the Financial Year 2026-27 Pursuant to Regulation of the SEBI (LODR) Regulation, 2015

2026-05-29 17:02:12
Announcement under Regulation 30 (LODR)-Change in Management

Appointment of Joint Managing Director - Akshit Mahendra Raycha

2026-05-29 16:59:52
Standalone Audited Financial Result For The Quarter And Year Ended On 31.03.2026

Standalone Audited Financial Result for the Quarter and Year ended on 31.03.2026

2026-05-29 16:55:39
Board Meeting Outcome for Outcome Of Board Meeting

Outcome of Board Meeting held on 29th May, 2026 for Consideration and Approval Audited Financial Result for the Quarter and Year ended 31st March, 2026 and other matters

2026-05-29 16:47:25
Board Meeting Intimation for Intimation Of Board Meeting To Be Held For Approval Of Audited Financial Results For Year Ended March 31, 2026 Of The Company

Zenith Healthcare Limited informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve We hereby inform you that the Board of Directors Meeting of Zenith Healthcare Limited is scheduled to be held on Friday, May 29th, 2026, at the registered office of the Company.

2026-05-19 18:12:04
Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2

Format of the Annual Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1 Name of Company Zenith Healthcare Ltd 2 CIN NO. L24231GJ1994PLC023574 3 Report filed for FY 2025-2026 Details of the Current block (all figures in Rs crore): 4 2 – year block period (Specify financial years)* FY 2024-25 and FY 2025-26 5 Incremental borrowing done in FY (T)(a) 0.00 6 Mandatory borrowing to be done through debt securities in FY (T) (b) = (25% of a) 0.00 7 Actual borrowing done through debt securities in FY (T)(c) 0.00 8 Shortfall in the borrowing through debt securities, if any, for FY (T – 1) carried forward to FY (T) (d) 0 8Quantum of (d), which has been met from (c)(e)* 0 9 Shortfall, if any, in the mandatory borrowing through debt securities for FY (T) { after adjusting for any shortfall in borrowing for FY(T – 1) which was carried forward to FY(T)}(f) = (b) – [(c) – (e)]{ If the calculated value is zero or negative, write “nil”}* 0 Details of penalty to be paid, if any, in respect to previous block (all figures in Rs crore): 2 – year Block period (Specify financial years)FY 2024-25 and FY 2025-2026 Amount of fine to be paid for the block, if applicable Fine = 0.2% of {(d) – (e)}#0.00 Name of the Company Secretary :-Mihir ShahDesignation :-Company Secretary and Compliance Officer Name of the Chief Financial Officer :- Prashant Gupta Designation : -Chief Financial Officer Date: 11/04/2026

2026-04-11 14:27:56
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Submission of Declaration of RTA under Regulation 74(5) of Depositories and Participants Regulation 2018.

2026-04-11 14:08:41
Closure of Trading Window

Intimation for Trading Window Closure

2026-03-24 15:34:10

Quarterly Financials

Consolidated Standalone
Particulars Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 4.02 3.49 3.89 3.07 2.57 3.03 2.31 3.43 3.15 2.27 2.48 2.62
YOY Revenue Growth % -23.75% 36.97% 6.28% 86.07% -35.98% -13.33% -40.76% 11.58% 22.55% -25.14% 7.71% -23.47%
Other Income 0.05 0.04 0.06 0.12 0.08 0.08 0.16 0.11 0.17 0.11 0.04 0.10
Total Income 4.06 3.54 3.95 3.19 2.65 3.11 2.47 3.53 3.32 2.38 2.53 2.72
Total Expenses + 3.81 3.42 3.85 3.40 2.50 2.93 2.58 3.48 3.34 2.16 2.28 3.14
Cost of Materials Consumed 1.54 1.34 1.99 1.54 0.89 1.63 1.14 1.73 1.11 0.73 0.83 1.61
Employee Benefit Expense 0.42 0.40 0.43 0.46 0.42 0.48 0.50 0.35 0.41 0.40 0.52 0.46
Other Expenses 0.93 1.33 1.31 1.06 0.99 0.70 0.82 1.56 1.27 0.98 0.86 0.90
Operating Profit 0.21 0.07 0.04 -0.33 0.07 0.10 -0.27 -0.06 -0.19 0.11 0.20 -0.52
OPM % 5.3% 2% 0.9% -10.7% 2.9% 3.3% -11.7% -1.7% -6.1% 4.8% 8.2% -19.8%
Profit Before Tax + 0.26 0.12 0.10 -0.21 0.16 0.18 -0.11 0.05 -0.03 0.22 0.25 -0.42
Tax Expense 0.00 0.00 0.00 0.07 0.00 0.09 0.18 -0.06 -0.01 0.08 0.02 -0.08
Tax % 0% 0% 0% - 0% 47.7% - -109.1% - 35.1% 9.2% -
Profit After Tax 0.26 0.12 0.10 -0.29 0.16 0.09 -0.29 0.11 -0.02 0.14 0.22 -0.34
EPS (Basic) 0.05 0.02 0.02 -0.05 0.03 0.02 -0.05 0.02 0.01 0.03 0.04 -0.06

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
Revenue from Operations 10.52 11.33 14.47 13.13 22.36 13.74
YOY Revenue Growth % -7.13% -21.71% 10.22% -41.29% 62.75% -
Other Income 0.41 0.43 0.27 0.38 0.52 0.46
Total Income 10.94 11.76 14.74 13.51 22.88 14.20
Total Expenses + 10.92 11.48 14.47 13.39 22.27 13.64
Cost of Materials Consumed 4.29 5.39 6.41 7.53 12.60 8.37
Employee Benefit Expense 1.80 1.75 1.73 1.55 1.64 1.32
Other Expenses 4.01 4.07 4.60 3.48 7.66 3.85
Operating Profit -0.40 -0.15 0.01 -0.26 0.09 0.10
OPM % -3.8% -1.3% 0% -2% 0.4% 0.7%
Profit Before Exceptional 0.02 0.28 0.28 0.12 0.61 0.56
Exceptional Items 0.00 0.00 0.00 0.00 0.00 0.00
Profit Before Tax + 0.02 0.28 0.28 0.12 0.61 0.56
Tax Expense 0.01 0.21 0.07 0.04 0.30 0.12
Tax % 68.1% 76% 26.2% 34.1% 48.7% 21.2%
Profit After Tax 0.01 0.07 0.20 0.08 0.31 0.44
EPS (Basic) 0.01 0.01 0.04 0.01 0.06 0.08

Balance Sheet

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
ASSETS
Non-Current Assets + 3.53 2.53 2.45 2.11 2.17 2.39
Property, Plant & Equipment 1.45 1.53 1.40 1.50 1.75 1.80
Capital Work in Progress 0.00 0.00 0.00 0.00 0.00 0.00
Non-Current Investments 0.01 0.00 0.00 0.00 0.00 0.00
Goodwill 0.00 0.00 0.00 0.00 0.00 0.00
Other Intangible Assets 0.00 0.00 0.00 0.00 0.00 0.00
Current Assets + 7.45 8.35 7.29 7.14 9.50 6.38
Inventories 2.92 2.27 1.98 3.26 3.62 3.26
Trade Receivables 2.09 2.42 2.01 2.31 3.25 1.69
Cash and Cash Equivalents 0.37 0.36 1.78 0.72 0.86 0.57
Current Investments 0.00 0.00 0.00 0.00 0.00 0.00
LIABILITIES & EQUITY
Total Equity 7.42 7.41 7.34 7.23 7.15 6.84
Equity Share Capital 5.37 5.37 5.37 5.37 5.37 5.37
Other Equity 2.05 2.03 1.96 1.86 1.78 1.47
Non-Current Liabilities 0.00 0.02 0.00 0.00 0.00 0.00
Current Liabilities 3.56 3.45 2.40 2.02 4.51 1.92
Total Liabilities 3.56 3.47 2.40 2.02 4.51 1.92

Cash Flow Statement

Particulars Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021
Cash from Operating Activities -0.83 0.67 1.93 -0.92 1.32 -1.47
Cash from Investing Activities 0.85 -1.09 -0.11 -0.03 -0.23 -0.19
Cash from Financing Activities -0.01 0.00 0.00 0.00 0.00 0.00
Net Increase/Decrease in Cash 0.01 -0.41 1.83 -0.95 1.09 -1.65